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The subjects of papers in this conference session concerned recovery ofthe Lyme
disease spirochete from patients, antibody responses and immunodiagnostic tests
for Lyme disease, and immunochemical studies of Lyme disease spirochetes.
During discussion, several general topics were addressed: (1) methods for detec-
tion of spirochetal antigens in synovial tissues, (2) evidence that antigens other than
those on the outer spirochetal membranes are immunogenic, (3) measurement ofthe
onset and duration of specific antibody responses in Lyme disease.
In regard to the first topic, it was pointed out that previous studies utilizing
synovial culture techniques for detecting the presence of spirochetes have not been
successful so far. The use of immunochemical stains for direct visualization seems
promising. Monoclonal antibody preparations or techniques that employ DNA
hybridization methods for detection of specific DNA may be useful for antigen de-
tection at various stages of the disease. Demonstration of spirochetal antigen in
immune complexes has not yet been successful.
In regard to isolation of spirochetes from the blood of Lyme disease patients, it
was pointed out that, as is the case with leptospires in leptospirosis infections, isola-
tion of the agent may be possible only during the first few days of clinical illness,
prior to development of specific antibody. Spirochetal isolation from Lyme disease
skin lesions has been possible in specimens obtained from the papillary dermis.
Discussion continued concerning the presence and activity of immunogens in
Lyme disease other than those present on the outer spirochetal membrane; antibody
binding to flagella has now been demonstrated. It was also mentioned that pro-
teoglycan may be a poorly degradable and persistent material which might be in-
volved in immunopathologic mechanisms having a role in prolongation of clinical
disease. In this regard preliminary results utilizing both immunofluorescence and
Western blot techniques indicate that Lyme disease patients do develop antibodies to
proteoglycan; patients with secondary syphilis have similar responses, suggesting the
presence of cross-reactive antigens in the two diseases.
The usefulness of specific antibody responses for differentiation of Lyme disease
from other forms of arthritis was reviewed. It was emphasized that the presence of
antibody correlates closely with the clinical stage of Lyme disease. Specific
spirochetal IgM responses measured by immunofluorescent techniques may be
delayed early in disease but aredemonstrable in 50 percent ofpatients witherythema
chronicum migrans. In one series, 94 percent of Lyme disease patients had elevated
IgG responses several weeks after onset of symptoms, and all patients having active
arthritis were antibody-positive. Elevated IgG titers have also been demonstrated in
patients with inactive Lyme disease, but the clinical significance of this observation
is not understood. One Lyme disease patient was described who has now been in
clinical remission for four years but continues to maintain elevated IgG antibody
levels. Both immunofluorescence and ELISA techniques were found to be sensitive
methods for determination of the presence of specific spirochetal antibody.
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